Checked
Neogenomics Inc
Nasdaq: NEO · Services-Testing Laboratories · Fort Myers, FL
- Revenue
- $727.3M
- +10.1% vs. prior year
- Net income
- -$108M
- -14.9% net margin
- Total assets
- $1.36B
Company details
As reported to the SEC
- SEC CIK
- 1077183
- Stock
- Nasdaq: NEO
- Legal Entity Identifier (LEI)
- 254900KXWYZIKXNFT521
- Industry (SIC)
- Services-Testing Laboratories (8734)
- Headquarters
- 9490 Neogenomics Way, Fort Myers, FL 33912
- Incorporated in
- Nevada
- Fiscal year end (SEC record)
- December 31
- Filer status
- Large accelerated filer
- Phone
- (239) 768-0600
- Employer ID (EIN)
- 74-2897368
- Last annual report
- 02/17/2026
- Last quarterly report
- 07/28/2026
Formerly: AMERICAN COMMUNICATIONS ENTERPRISES INC (until 02/05/2002)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $727.3M | $660.6M | $591.6M | $509.7M | $484.3M |
| Gross profit | $314.3M | $290.1M | $244.6M | $187.9M | $187.1M |
| Operating income | -$115.9M | -$92.11M | -$107.7M | -$157.6M | -$118.8M |
| Net income | -$108M | -$78.73M | -$87.97M | -$144.3M | -$8.35M |
| Research and development | $37.08M | $31.16M | $27.31M | $30.33M | $21.87M |
| Total assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B |
| Total liabilities | $523.3M | $735.7M | $739.7M | $742M | $761.5M |
| Shareholders' equity | $836.6M | $902.3M | $941.5M | $998M | $1.11B |
| Cash and cash equivalents | $159.6M | $367M | $342.5M | $263.2M | $316.8M |
| Long-term debt | $341.9M | $340.3M | $538.2M | Not reported | Not reported |
| Cash from operations | $5.23M | $7.02M | -$1.95M | -$65.99M | -$26.72M |
| Capital expenditures | $27.01M | $41.06M | $28.75M | $30.89M | $64.14M |
Subsidiaries
5 companies that Neogenomics Inc owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| Inivata Limited, a UK limited company | SEC 10-K |
| NeoGenomics Bioinformatics, Inc., a Florida corporation | SEC 10-K |
| NeoGenomics Laboratories, Inc., a Florida corporation | SEC 10-K |
| Suzhou NeoGenomics Pharmaceutical Research Co., Limited, a Suzhou, China corporation | SEC 10-K |
| Trapelo Health, LLC, a Delaware limited liability company | SEC 10-K |
Recent filings
142 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
46 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Neogenomics Inc in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other services-testing laboratories
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| UL Solutions Inc.ULS | Northbrook, IL | $3.05B | $325M |
| 20/20 Biolabs, Inc.AIDX | Rockville, MD | $2.05M | -$3.74M |
| Hypha Labs, Inc.FUNI | Las Vegas, NV | Not reported | -$3.1M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Neogenomics Inc's CIK number?
- Neogenomics Inc's SEC Central Index Key (CIK) is 1077183.
- What is Neogenomics Inc's stock ticker?
- Neogenomics Inc trades as Nasdaq: NEO.
- What was Neogenomics Inc's revenue?
- Neogenomics Inc reported revenue of $727.3M for the fiscal year ended Dec 31, 2025, +10.1% from the year before.
- When does Neogenomics Inc's fiscal year end?
- Neogenomics Inc's fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Neogenomics Inc headquartered?
- Neogenomics Inc's principal executive office on file with the SEC is in Fort Myers, FL.
- What companies does Neogenomics Inc own?
- Neogenomics Inc lists 5 subsidiaries in its SEC filings and other public records, including Inivata Limited, a UK limited company, NeoGenomics Bioinformatics, Inc., a Florida corporation, NeoGenomics Laboratories, Inc., a Florida corporation.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026